- Home
- LAZR vs ELDN Comparison
LAZR vs ELDN Comparison
Compare LAZR & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAZR
- ELDN
- Stock Information
- Founded
- LAZR 2012
- ELDN 2004
- Country
- LAZR United States
- ELDN United States
- Employees
- LAZR N/A
- ELDN N/A
- Industry
- LAZR Auto Parts:O.E.M.
- ELDN Biotechnology: Pharmaceutical Preparations
- Sector
- LAZR Consumer Discretionary
- ELDN Health Care
- Exchange
- LAZR Nasdaq
- ELDN Nasdaq
- Market Cap
- LAZR 153.9M
- ELDN 178.4M
- IPO Year
- LAZR N/A
- ELDN N/A
- Fundamental
- Price
- LAZR $4.72
- ELDN $2.87
- Analyst Decision
- LAZR Hold
- ELDN Strong Buy
- Analyst Count
- LAZR 7
- ELDN 1
- Target Price
- LAZR $37.83
- ELDN $16.00
- AVG Volume (30 Days)
- LAZR 1.9M
- ELDN 173.9K
- Earning Date
- LAZR 05-14-2025
- ELDN 05-14-2025
- Dividend Yield
- LAZR N/A
- ELDN N/A
- EPS Growth
- LAZR N/A
- ELDN N/A
- EPS
- LAZR N/A
- ELDN N/A
- Revenue
- LAZR $73,313,000.00
- ELDN N/A
- Revenue This Year
- LAZR $17.39
- ELDN N/A
- Revenue Next Year
- LAZR $53.70
- ELDN N/A
- P/E Ratio
- LAZR N/A
- ELDN N/A
- Revenue Growth
- LAZR N/A
- ELDN N/A
- 52 Week Low
- LAZR $3.30
- ELDN $2.00
- 52 Week High
- LAZR $32.70
- ELDN $5.54
- Technical
- Relative Strength Index (RSI)
- LAZR 45.27
- ELDN 49.18
- Support Level
- LAZR $3.83
- ELDN $2.85
- Resistance Level
- LAZR $4.80
- ELDN $3.12
- Average True Range (ATR)
- LAZR 0.27
- ELDN 0.26
- MACD
- LAZR 0.09
- ELDN 0.01
- Stochastic Oscillator
- LAZR 31.84
- ELDN 34.78
About LAZR Luminar Technologies Inc.
Luminar Technologies Inc is an automotive technology company ushering in a new era of vehicle safety and autonomy. It operates its business through the following segments: Autonomy Solutions and Advanced Technologies and Services. The majority of its revenue is generated from the Autonomy Solutions segment, which engages in the design, manufacturing, and sale of LiDAR sensors, catering mainly to the OEMs in the automobile, commercial vehicle, robo-taxi, and adjacent industries. The Advanced Technologies and Services segment provides semiconductors and related components, as well as design, test, and consulting services to the Autonomy Solutions segment and various third-party customers. Geographically, the company derives its key revenue from North America.
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.